Lysosomal degradation of the receptor tyrosine kinase cMet requires receptor ubiquitination by the E3 ubiquitin ligase Cbl followed by clathrin-dependent internalization. A role for Cbl as an adaptor for cMet internalization has been previously reported. However the requirement for Cbl ubiquitin ligase activity in this process and its mode of recruitment to cMet has yet to be determined. Cbl can directly bind cMet at phosphotyrosine 1003, or indirectly via Grb2 to phosphotyrosine 1356 in the multisubstrate-binding domain of cMet. The direct binding of Cbl with cMet is critical for receptor degradation and not receptor internalization. Here we show a strict requirement for Grb2 and the ubiquitin ligase activity of Cbl for cMet endocytosis. Receptor internalization was impaired by siRNA depletion of Grb2, over expression of dominant negative Grb2 mutants, and point mutations in the cMet multisubstrate docking site that inhibits the direct association of Grb2 with cMet. The requirement for Grb2 was specific and did not involve the multiadaptor Gab1. cMet internalization was impaired in cells expressing an ubiquitin ligase deficient Cbl mutant or conjugation-deficient ubiquitin, but was unaffected in cells expressing a Cbl mutant that is unable to bind cMet directly. Expression of a Cbl-Grb2 chimera rescued impaired cMet endocytosis in cells depleted of endogenous Grb2. These results indicate that the ubiquitin ligase activity of Cbl is critical for clathrindependent cMet internalization, and suggest a role for Grb2 as an intermediary linking Cbl ubiquitin ligase activity to this process.
INTRODUCTION
Activation of the receptor tyrosine kinase (RTK) cMet by binding to its physiological ligand Hepatocyte Growth Factor (HGF) results in increased cell proliferation and cell motility, processes critical for embryonic development, tissue regeneration and homoeostasis (reviewed in 1). Persistent cMet signaling occurs in many human cancers, correlating closely with early stage invasion, dissemination and metastases (reviewed in 1,2). Once activated by ligand binding, cMet is normally endocytosed exclusively through clathrin-coated pits (3, 4) and then inactivated by lysosomal degradation (3, 5) . Although several mechanisms likely contribute to sustained cMet signaling in cancer (6) (7) (8) (9) (10) (11) (12) , dysregulated receptor internalization and degradation have recently emerged as novel mechanisms for cMet induced cell transformation and the increased neoplastic growth of human tumors (13) (14) (15) (16) .
Endocytic studies on other RTKs, most notably the Epidermal Growth Factor Receptor (EGFR), suggest that modification of the endocytic trafficking machinery by the activated receptor and/or its associated signaling molecules regulates receptor internalization and degradation. For example, the signaling adaptor Grb2 has been shown to function as an important initiator of EGFR endocytosis (17) (18) (19) (20) . siRNA-mediated depletion of Grb2 and over expression of Grb2-SH3 mutants deficient in binding downstream signaling molecules blocks the recruitment of EGFR into clathrin-coated pits and subsequent receptor internalization, with negligible effects on the downstream activation of mitogen-activated protein kinase (MAPK) or phosphatidylinositol 3-kinase (PI3K) (19) . Grb2 functions to regulate EGFR internalization through the recruitment of the E3 ubiquitin ligase Cbl (20) (21) (22) . However, it remains unclear if the requirement for Grb2 on EGFR endocytosis is mediated solely through interactions with Cbl, functions at the level of EGFR ubiquitination, involves additional Grb2-dependent interactions or extends to other RTKs.
cMet and the EGFR are prototypic members for distinct RTK subfamilies and as such exhibit unique structural and functional characteristics. In contrast to the EGFR, cMet is a heterodimer composed of an extracellular α chain that is disulphide-linked to a transmembrane β chain that contains cytoplasmic tyrosine kinase activity (23) (24) (25) . The extracellular domain of cMet contains a distinctive β-propeller fold that mediates ligand binding (26) . Ligand binding induces the autophosphorylation of cMet and EGFR at multiple tyrosines in their respective C-terminal regions enabling the recruitment and subsequent activation of shared downstream adaptor and signaling molecules. The EGFR possesses six tyrosine transphosphorylation sites dispersed throughout the C-terminal region (reviewed in 27), whereas cMet contains two key tyrosine phosphorylation sites at positions 1349 and 1356 in a unique multisubstrate-docking site, that function to concomitantly activate multiple downstream signaling pathways (28, 29) . In contrast to cMet which contains one binding site for the signaling adaptor Grb2 at phosphotyrosine 1356 (28, 30) , Grb2 binds EGFR directly at two sites (31) . Moreover, Grb2 appears to play a minor role in signaling events downstream of ligand activated cMet in vivo (32) (33) (34) ) when compared to the EGFR (34) . The adaptor protein Gab1 binds to two sites in the multisubstrate-docking site of cMet; directly at phosphotyrosine 1349 or indirectly via the adaptor Grb2 to phosphotyrosine 1356 (35) (36) (37) (38) . Gab1 recruitment is essential for the induction of cell motility, branching morphogenesis and the formation of crypts in three-dimensional matrices, hallmarks of cMet signaling (29, 33, (39) (40) (41) . Given these differences in adaptor recruitment and biological activity, some differences may exist in the regulatory mechanisms controlling cMet versus EGFR internalization.
The E3 ubiquitin ligase Cbl has been shown to mediate the ubiquitination of ligand-activated cMet (4, 5, 14, 42, 43) , receptor internalization (4) and degradation (13, 14) . Cbl recruitment via its tyrosine kinase binding domain to phosphotyrosine 1003 of cMet, has been shown to contribute to receptor ubiquitination (13, 14, 42) and degradation in lysosomes (13, 14, 43) . Cbl has been shown to function as an adaptor important for cMet internalization through clathrin-coated pits, via the recruitment of the endophilin-CIN85 complex (4) . However, a requirement for Cbl ubiquitin ligase activity and its mode of recruitment for cMet internalization was not examined. In this study we report that the ubiquitin ligase activity of Cbl is important for clathrin-mediated cMet internalization. Moreover, Grb2 bound directly to the cMet multisubstrate docking site acts as an intermediary for Cbl ubiquitin ligase activity in these events.
(Jackson ImmunoResearch Laboratories Inc, PA), Alexa 488 or Alexa 594 -labeled goat anti-mouse, antirabbit or anti-rat secondary antibodies (Invitrogen Corp, CA). A pLXSN plasmid encoding wt-cMet was previously reported (44) . pLXSN plasmids encoding the full-length Met mutants N1358H and Y1349,1356F were generously provided by Pascal Peschard and Morag Park (McGill University). The K1110A allele encodes a Met receptor lacking kinase activity (45, 46) . The K1110A mutation was generated through a PCR-based SOEing approach (47) using wild type cMet cDNA as a template, Pfu DNA polymerase, and the primers, 5'-CAAGCTAGCCACAGCACAGTG-3', 5'-CCCATCCTAACTAGTGGGGAC-3', 5'-CACTGTGCTGTGGCTAGCTTG-3', and 5'-GCTCTAGAACTAGTGGATCCC-3'. The final ~1.3 kb PCR product was subcloned between the SpeI and XcmI sites of pLXSN-Metwt, resulting in a full-length Met gene with the K1110A mutation and verified by DNA sequencing. The various Met alleles were subcloned from the plasmid pLXSN into the Murine Stem Cell Virus (MSCV) vector pMSCVpuro (BD Biosciences, CA) for retroviral-mediated transfection in the target cell lines. pYFP-N1 plasmids encoding Grb2 and Grb2-mSH3 were kindly provided by Lawrence Samelson (National Institutes of Health) (48) . The pEGFP plasmids encoding Cbl, Cbl-SH2, Cbl-SH2/R86A, Grb2-SH2 and Grb2/R86A were kindly provided by Alexander Sorkin (University of Colorado Health Sciences Center) (17, 22) . pcDNA3-Myc-UbR and pcDNA3-MycUbRL8A/I44A were kind gifts from Inger Madshus (Norwegian Radium Hospital, Norway) (18) . Plasmids encoding HA-tagged Cbl (wt), 70Z-Cbl and Cbl-G306E were kindly provided by Jannie Borst (The Netherlands Cancer Institute, The Netherlands) (20) .
Cell lines-The H10 cell line derived from kidney epithelial cells from embryos of cMet null -/-mice (49) was a generous gift of Dr. Lloyd Cantley (Yale University School of Medicine). Polyclonal H10 cell lines expressing cMet alleles were generated by retroviral transfection essentially as described (50) , except that 1-5 µg/ml of puromycin was used for selection and limiting dilution was not performed. Cell lines were analyzed for cMet expression by western blotting with the anti-cMet antibody DL-21 (Upstate Biotechnology, NY), and those cell lines that exhibited similar cMet levels were chosen for further analysis. The parental H10 cMet null -/-cell line was maintained in DMEM/F-12(1:1) with 10% FBS. H10 derivatives stably expressing wild type or mutant cMet alleles were grown in the same medium containing 5 µg/ml puromycin. Human mammary epithelial cells (T47D) stably expressing full-length human cMet (T47D/cMet) were a generous gift of Morag Park (McGill University) and were maintained in Dulbecco's modified eagle's medium (DMEM) containing 10% FBS, supplemented with 400 µg/mL G418.
siRNAs and cell transfections-For small interfering RNAs (siRNA) depletion studies, cells were grown on coverslips in 60 mm plates and transfected with Smartpools™ containing four siRNA duplexes for Gab1, Grb2, Shc or a control siRNA using Lipofectamine 2000 reagent (Invitrogen Corp, CA). Typically each coverslip of cells was transfected with 200 pmol of siRNA and 8 µl of Lipofectamine 2000. T47D/cMet cells were routinely cultured on coverslips coated with 100 µg/ml poly-lysine prior to experimentation. All experiments were routinely performed 72 hr after siRNA transfection. Cell transfections using plasmids were performed as previously described (3) .
Immunoprecipitation and GST pull down Assays-For immunoprecipitation (IP) studies, cells were washed twice with ice-cold PBS (137 mM NaCl, 2.7 mM KCl, 8.2 mM Na 2 HPO 4 , 1.5 mM KH 2 PO 4 ) and lyzed on ice in RIPA buffer (50 mM Tris-HCl, pH 7.4, 1% NP-40, 0.5% Nadeoxycholate, 0.1% SDS, 150 mM NaCl, 1 mM EDTA) with protease inhibitors (2 µg/ml aprotinin, 2 µg/ml leupeptin, 2 µg/ml pepstatin) and phosphatase inhibitors (10 mM NaF, 2 mM Na 3 VO 4 ). Cell lysates were cleared by centrifugation at 12,000 xg at 4 o C and then 500-1000 µg of each lysate was incubated with 5 µg of primary antibody overnight at 4 o C. Antibodyprotein complexes were precipitated with 50µl protein A/G agarose solution (Pierce Biotechnology Inc, IL) by rotation at 4 o C for 4 hr. The protein-beads complex were collected by centrifugation at 1000xg for 5 min, washed with lysis buffer 3 times, and then resuspended in SDS loading buffer and fractionated by SDS/PAGE. For GST pull downs, the cell lysates were prepared in Lysis buffer (1% Triton X100, 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 2 mM EDTA, 2 by guest on September 1, 2017 http://www.jbc.org/ Downloaded from µg/ml aprotinin, 2 µg/ml leupeptin, 2 µg/ml pepstatin, 10 mM NaF, 2 mM Na 3 VO 4 ). Lysates (0.5-1.0 mg protein) were incubated with the appropriate GST fusion proteins prebound to glutathione-Sepharose beads (Sigma) overnight at 4 o C. Beads were washed three times in Lysis buffer followed by a final wash in 10 mM TrisHCl pH 7.4, then analyzed by SDS/PAGE.
Cell surface biotinylation and western analysis-The biotinylation and receptor internalization assays were described previously (3) . Briefly, cells were surface biotinylated at 4°C for 30 min with EZ-link NHS-SS-biotin (Pierce Biotechnology Inc, IL). Surface expressed proteins were isolated directly using streptavidin-agarose beads as described by the manufacturer (Pierce Biotechnology Inc, IL) and identified by western analysis. Western analysis was performed using ECL (GE Healthcare Life Sciences, Sweden) and the resulting digitized blots were quantified using AlphaEase v3.1.2 Software (Alpha Innotech Corp, CA).
Flow cytometry analysis-cMet internalization from the plasma membrane was measured by assaying the residual amount of immunoreactive receptor accessible at the cell surface to a monoclonal antibody recognizing an extracellular epitope. Briefly, cells grown to 80% confluence on 60 mm dishes were sera-starved for 4-6 hr and then stimulated with 100 ng/ml InlB at 37°C under steady state conditions to drive cMet internalization. At the indicated times, receptor endocytosis was terminated by placing the cells on ice. The cells were immediately rinsed with icecold PBS and residual surface bound InlB was stripped using three consecutive 5 min ice-cold acid washes (DMEM, pH 3.5). Cells were detached with PBS containing 5 mM EDTA, and then resuspended in ice-cold FACS buffer (PBS containing 2% FBS). Cells were incubated with anti-cMet antibody (AF276, R&D System, MN) in FACS buffer at 4 o C for 1 hr, washed three times with ice-cold FACS buffer, and then incubated with Alexa 488 -conjugated secondary antibody in FACS buffer at 4°C for 30 min. Following three ice-cold washes with FACS buffer the cells were analyzed using a FACS Canto flow cytometer or fixed with 2% paraformaldehyde/PBS for later analysis. Cell viability, as determined by the exclusion of propidium iodide, routinely exceeded 95%. 20,000 cells were analyzed for each sample in triplicate for each condition in each experiment. The mean fluorescence intensity (MFI) of the cells at each time point was analyzed and compared to a negative control using control antibody only. The MFI values for each condition were averaged and the S.E. calculated across all experiments. The relative percentage of residual cell surface cMet at each time point (t x ) was calculated relative to the MFI of cells without internalization (t 0 ) as (MFI t x -MFI control antibody only/MFI t 0 -MFI control antibody only) x 100.
InlB labeling, confocal microscopy and analysis-The purification and labeling of recombinant His 6 -tagged InlB has been described in detail elsewhere (3) . For confocal microscopy, cells grown on coverslips were incubated in media containing 5.0 µg/ml of Alexa 594 -labeled Tfn with 100 ng/ml InlB or HGF for 10 min at 37°C, then fixed immediately after each experiment using 4% paraformaldehyde (Ted Pella Inc, CA) in PBS. Residual paraformaldehyde was quenched using 50 mM NH 4 Cl/PBS and cells were then permeabilized with 0.05% (w/v) saponin (or 0.1% Triton X-100/PBS for HGF staining) for 20 min and then blocked with 10% goat serum in PBS. All antibody dilutions were performed in 5% goat serum/PBS with 0.05% saponin for 1 hr. In studies staining for HGF, saponin was omitted from the buffers. Coverslips were mounted and observed using a Zeiss LSM 510 confocal microscope with a 63x oil (1.4NA) immersion objective. Samples were visualized with the 488 nm and 543 nm laser lines and emission filter sets at 505-530 nm for YFP and Alexa 488 detection or 585-615 nm for Texas Red and Alexa 594 detection, respectively. Figure presentation was accomplished in Adobe Photoshop V 6.0. Quantification of co localization and internal fluorescence intensity were accomplished using Metamorph v5.0 (Molecular Devices, CA) as described previously (3) . All pixel intensity levels were normalized relative to control values, expressed as a percentage ± Standard Error (S.E.) and differences statistically verified by ANOVA using GraphPad Prism Software (GraphPad Software Inc, CA). (28) . To determine if autophosphorylation of these tyrosine residues is critical for cMet internalization, wild type (wt) or mutant cMet was expressed in cells immortalized from the kidneys of cMet null (-/-) mice. These epithelial cMet (-/-) cells undergo chemotaxis and branching morphogenesis in response to EGF and TGFα but not HGF, indicating that cMet signaling is specifically abrogated in these cells (49) . We generated several cell lines stably expressing moderate levels of wt or mutant cMet, including tyrosine kinase deficient K1110A cMet (KinDcMet) and the multisubstrate-docking site mutant Y1349, 1356F (YF-cMet), which is deficient in Gab1 and Grb2 binding. siRNA-mediated depletion of clathrin heavy chain inhibited wtcMet internalization ( Fig. S1 ) confirming that cMet internalization is clathrin-dependent in these cells, consistent with our previous studies using T47D/cMet and Vero cells (3) .
RESULTS

The tyrosine kinase activity and the docking
We previously reported that the soluble form of the Internalin B (InlB) protein of Listeria monocytogenes mimics HGF-induced cMet internalization and degradation (3). In addition to being presented as a soluble protein, InlB is also found anchored to the cell surface of bacteria (51) . The surface anchored form of InlB mediates bacterial uptake into host cells (5), whereas soluble InlB is thought to modulate host transcriptional responses (52, 53) . We previously reported that HGF and soluble InlB are internalized with cMet via a clathrin-dependent mechanism (3). Interestingly, evidence indicates that the internalization of soluble InlB or HGF probably occurs through a mechanism that differs from that utilized by bacteria expressing surface anchored InlB. Although the uptake of Listeria and cMet activated by soluble ligands involves select components of clathrin coated pits (5), Listeria entry requires PI3K activity (54) whereas the internalization of soluble HGF or InlB does not depend on this kinase (3). Since soluble InlB and HGF are internalized through identical pathways, we used InlB as an initial ligand to examine the molecular control of cMet endocytosis and then validated key findings using the physiological ligand HGF.
Western analysis of cell lysates prepared from the stable cell lines expressing wt or mutant cMet confirmed that treatment with InlB for 15 min at 37°C caused phosphorylation of wt and the YFcMet mutant on tyrosine residues 1234 and 1235 in the activation loop, but not on kinase-dead cMet (KinD-cMet) (Fig. 1A) . Ubiquitination of wt-cMet but not KinD-cMet was increased in response to InlB. A low level of ubiqitinated YF-cMet was detected under these conditions, consistent with the direct association of Cbl to phosphotyrosine 1003 of cMet, independently of Grb2 binding (14) . Cbl phosphorylation was not detected in unstimulated cells or in cells stably expressing KinD-cMet following treatment with ligand (Fig.  1A ). In keeping with previous results (14, 36) , cMet-mediated phosphorylation of Cbl was reduced in cells expressing YF-cMet relative to cells expressing wt-cMet. This is consistent with a role for Grb2 in recruiting Cbl to cMet via phosphotyrosine 1356. Surface biotinylation assays were used to confirm the cell surface expression of wt and mutant cMet in each of the polyclonal cell lines (Fig. 1B ). Cells were surface biotinylated at 4°C for 30 min using NHS-SSBiotin. Cell lysates were then prepared, biotinylated proteins isolated by Streptavidin pull down and analyzed by westerns. Comparable levels of wt and mutant cMet were detected at the cell surface of the cell lines (Fig. 1B) . No cMet was detected in the parental null cells, consistent with previous reports (49) .
Using a GST pull down assay, we verified that Grb2 bound to wt-cMet in response to InlB, but not to YF-cMet or KinD-cMet (Fig. 1C) . No Grb2 binding was detected in the absence of ligand, confirming that Grb2 binding to wt-cMet was specific and dependent on cMet autophosphorylation.
Similarly, Gab1 phosphoryation in response to InlB was detected in null cells expressing wt-cMet, but not in cells expressing the YF-or KinD-cMet mutants ( Fig.  1D ) consistent with previous reports using fibroblasts and HEK293 cells (35, 55) . Together, these data confirm that the recruitment of Gab1 and Grb2 to cMet is disrupted in the YF-and KinD-cMet mutants, but not in cells expressing wt-cMet.
We next examined ligand-induced internalization of wt and mutant cMet using a flow cytometric method that measures the amount of immunoreactive receptor remaining on the cell surface following ligand treatment. Briefly, cMet null cells stably expressing wt or mutant cMet were incubated in the presence or absence of InlB (100 ng/ml) for increasing periods of time at 37°C. Following incubation, the cells were then chilled on ice to prevent further receptor trafficking and cMet remaining on the cell surface was labeled specifically with a cMet specific antibody under non permeabilized conditions. Flow cytometry analysis was then used to quantify the relative number of immunoreactive receptors remaining on the cell surface under these conditions (Fig. 1E ). All cell populations expressed similar levels of surface cMet under control conditions (i.e. no receptor internalization at 4°C), consistent with their initial selection based on similar levels of cell surface receptor expression (data not shown). As expected, reduced levels of wt-cMet were detected on the cell surface relative to cells incubated in the absence of InlB, consistent with ligand inducedreceptor internalization. In contrast to wt-cMet, higher cell surface levels of YF-cMet and KinDcMet were routinely detected at each time point. Following an initial decrease in detected cell surface levels of KinD-cMet and YF-cMet at 5 and 10 min respectively, receptor levels remained constant thereafter for up to 20 min of ligand treatment. The initial reduction in the surface levels of cMet could be the result of the constitutive internalization of cMet consistent with our earlier studies (3) or steric hindrance of antibody binding to cMet. We confirmed our flow cytometry studies using Alexa-labeled InlB (Alexa-InlB) as a ligand to examine the internalization of wt and mutant cMet by confocal microscopy (Fig. S2) . Following incubation for 10 min at 37°C in media containing Alexa-InlB, internalized ligand was detected with co internalized Texas-Red labeled Transferrin (Tfn) in cells expressing wt-cMet. Conversely, decreased levels of internalized InlB were detected in cells expressing kinase-dead (KinD) cMet or the cMet mutant lacking a functional Gab1/Grb2 binding site (YF). Rather, large spots of InlB fluorescence were detected on the surface of cells expressing YF-cMet. Clathrin-mediated Tfn uptake was unaffected in null cells expressing YFcMet or KinD-cMet, consistent with a specific block in cMet internalization rather than saturation of the clathrin-dependent endocytic machinery (Fig. S1) . Thus, activation of the cMet tyrosine kinase activity and subsequent recruitment of one or more of the proteins that are known to associate with phosphotyrosines 1349 and 1356 are required for cMet internalization through clathrin-coated pits.
Grb2 is required for cMet internalizationOur data indicating the dependence on phosphotyrosines 1349 and 1356 in the multisubstrate docking region for cMet internalization raised the possibility that the adaptors Grb2 and/or Gab1 could be required for this process. To test this idea we used specific siRNAs to deplete T47D/cMet cells of endogenous Grb2. T47D/cMet cells are a human mammary epithelial cell line that stably express human cMet on their surface and have been extensively used on studies examining cMet signaling and endocytosis in the past (3, 13, 14, 44) . Endogenous Grb2 was weakly detected by western analysis in T47D/cMet cells transfected with Grb2-siRNAs ( Fig. 2A) . Conversely, comparable levels of endogenous TfR, actin and cMet were observed in Grb2-depleted T47D/cMet cells as well as untransfected cells, and T47D/cMet cells transfected with a control siRNA, demonstrating the specificity of the siRNA treatment. Western analysis confirmed that siRNA-mediated depletion of Grb2 did not reduce cMet phosphorylation in response to InlB (10 min at 37°C) (Fig. 2B) . Conversely, cMet ubiquitination and Cbl phosphorylation were reduced by Grb2-depletion. siRNA-treated cells were coincubated with Tfn and HGF or Alexa-InlB for 10 min at 37°C and ligand internalization was measured by confocal microscopy. cMet internalization in response to HGF or InlB was reduced 51.3 ± 4.85% and 74.4 ± 2.87% respectively in Grb2-depleted cells versus cells transfected with a control siRNA (Fig. 2C) . Comparable levels of co internalized Tfn were detected in control and Grb2-depleted T47D/cMet cells, indicating that loss of Grb2 led to a specific block in cMet internalization and not a general defect in clathrin-mediated endocytosis (Fig. 2C,  Fig. S3 ). siRNA-mediated Grb2 depletion caused a comparable block in cMet endocytosis in cMet null cells stably expressing wild type receptor, indicating that endogenous Grb2 is required for cMet uptake in different cell types (Fig. S4) . We confirmed the requirement for Grb2 in cMet internalization using flow cytometry. As expected, we observed higher levels of surface cMet in Grb2-depleted T47D/cMet cells relative to cells transiently transfected with a nonspecific control siRNA following receptor activation with InlB (Fig. 2D) . Thus, loss of Grb2 led to a specific block in HGF-and InlB-induced cMet internalization and not a general inhibition in clathrin-mediated endocytosis.
Interactions (57, 58) and the large GTPase Dynamin (59) . The mutations P49L and G203R in the N-and C-terminal SH3 domains respectively (Fig. 3A) , block these interactions in a double Grb2 mutant (Grb2-mSH3). If Grb2 is required for cMet internalization, we reasoned that in contrast to wt Grb2, expression of a mutant expressing only the SH2 domain of Grb2 (Grb2-SH2) would function as a dominant negative mutant and block the binding of endogenous Grb2 to cMet. Conversely, the SH3 double mutant (Grb2-mSH3) would be unable to form productive complexes with downstream effectors and hence function to impede cMet internalization when expressed in cells. T47D/cMet cells were transfected with wt or mutant Grb2 (Grb2-SH2, Grb2-mSH3) labeled at their C-termini with Enhanced Yellow Fluorescent Protein (EYFP) (Fig. 3A) to enable detection of the over expressed proteins. The presence of EYFP has been shown not to interfere with the function of wt Grb2 or its mutants (22). Control westerns detected comparable levels of activated cMet in mock transfected T47D/cMet cells, and in cells expressing wt or mutant Grb2 (Fig. S5 ) in response to InlB. In contrast to wt Grb2, expression of Grb2-mSH3 and to a lesser extent Grb2-SH2, resulted in reduced ERK activation. The reduced activation of ERK observed in cells expressing Grb2-SH2 was consistent with the lower transfection rate routinely obtained using this construct (Fig. S5) . The effect of wt and mutant Grb2 on Alexa-InlB uptake in T47D/cMet cells was quantified using confocal microscopy. Following treatment with Alexa-InlB for 10 min at 37°C to stimulate cMet internalization, comparable levels of internalized ligand were detected in control cells expressing EYFP only and in cells expressing wt Grb2 (Figs. 3B & S6) .
Cbl ubiquitin ligase activity is required for cMet internalization-Consistent with our data demonstrating a requirement for Grb2 in cMet internalization, we previously reported that receptor endocytosis is impaired in cells over expressing dominant negative Dynamin (3). However, it remains unclear which additional Grb2-mediated interactions are required for the internalization of soluble InlB/cMet or HGF/cMet complexes. Our initial studies focused on the E3 ubiquitin ligase Cbl for several reasons. Grb2-recuited Cbl ubiquitin ligase activity has been implicated in the clathrin-dependent internalization of EGFR in response to EGF (17) (18) (19) (20) (21) . Grb2 has been shown to constitutively associate with the E3 ubiquitin ligase Cbl (60) (61) (62) and is recruited to cMet in response to receptor activation (4, 14) . Over expression of a Cbl mutant encompassing the N-terminal TKB and RING finger domains has been reported to decrease cMet internalization, possibly by blocking recruitment of CIN85-Endophilin complexes to cMet (4) . Although these studies demonstrated a role for Cbl in cMet internalization, they focused only on the adaptor functions of Cbl and did not examine the requirement for the ubiquitin ligase activity of Cbl for cMet internalization. Thus, the indirect recruitment of Cbl ubiquitin ligase activity through Grb2 could contribute to Grb2 function in cMet endocytosis.
We tested the idea that the ubiquitin ligase activity of Cbl was important for cMet internalization using confocal microscopy. T47D/cMet cells were transfected with wt Cbl or Cbl mutants defective in either ubiquitin ligase activity (70Z-Cbl), or binding to phosphotyrosine 1003 (Cbl-G306E) (Fig. 4A) . Previous studies have demonstrated that Cbl binds cMet and induces its ubiquitination in response to HGF, whereas the ubiquitin ligase deficient mutant Cbl-70Z interacts with cMet but is unable to induce receptor ubiquitination (4, 13, 14, 43) . The cells were allowed to co internalize Tfn with AlexaInlB or HGF for 10 min at 37°C and the relative amount of internalized ligand examined by confocal microscopy (Fig.  S7) . cMet internalization was unaffected in mock-transfected control cells and in cells expressing wt Cbl or G306E, a mutant unable to bind RTKs directly. However, in cells over expressing the ubiquitin ligase deficient mutant 70Z-Cbl, internalized HGF and Alexa-InlB staining was reduced to 33.5 ± 2.4% and 50.4 ± 2.6% of control levels respectively (Fig. 4B) . To confirm the requirement of Cbl-mediated ubiquitination for cMet internalization, we took advantage of wellcharacterized ubiquitin mutants that have altered conjugation and binding properties (Fig. 4C) . Cbl functions to covalently attach monoubiquitin to substrate proteins via the C-terminal glycine residues of ubiquitin. The ubiquitin mutant UbR lacks these glycine residues important for substrate conjugation. However, UbR retains the ability to interact with intracellular proteins harboring ubiquitin-binding domains, including the ubiquitin-interacting motif (UIM). Thus when expressed in cells, UbR functions to block the interaction of ubiquitinated proteins with proteins harboring a UIM (18) . Using confocal microscopy, we examined the effect of transiently expressing UbR on cMet internalization in T47D/cmet cells. UbR containing the double mutation L8A/I44A (UbR-L8A/I44A) that blocks the interaction of UbR with UIMs was used as a control (Fig. S8) . As shown in Fig. 4D , expression of UbR reduced cMet internalization to 33.7 ± 3.4% relative to mock-transfected control cells or cells expressing the double mutant UbR-L8A/I44A. Tfn uptake was unaffected in cells expressing UbR or UbR-L8A/I44A. This is the first report indicating that the ubiquitin ligase activity of Cbl is important for cMet internalization in response to soluble InlB as well as HGF.
Recruitment of Cbl through the SH2 domain of Grb2 supports cMet internalization-Our data indicating a role for Grb2 and the ubiquitin ligase activity of Cbl for the internalization of soluble ligand/cMet complexes suggested that the recruitment of a Grb2-Cbl complex could be important for cMet internalization. To test this we transiently transfected T47D/cMet siRNAdepleted of endogenous Grb2 with a chimeric protein in which wt Cbl was tagged with EYFP at its N-terminus and the SH2 domain of Grb2 at its C-terminus (Cbl-SH2) (22). In the absence of endogenous Grb2, Cbl recruitment to the docking site of cMet would be predicted to occur via the Grb2-SH2 domain at the C-terminal of the chimeric protein thereby reversing the inhibition of cMet endocytosis imposed by Grb2 depletion. A second mutant chimeric protein deficient in cMet binding (Cbl-SH2/R86A) (22) was used as a control (Fig. 5A) . In these studies, T47D/cMet cells were co transfected with Grb2-targeted siRNA and with Cbl-SH2, Cbl-SH2/R86A or mock transfected cells as a control. The cells were allowed to co internalize Alexa-InlB and HGF for 10 min at 37°C. Given the low double transfection rates routinely observed using these constructs, we examined the relative amounts of internalized ligand using confocal microscopy (Fig. 5B) . Internalized HGF was detected by co staining with an antibody specific for HGF. Expression of the chimeric protein Cbl-SH2 in Grb2-depleted cells caused increased uptake of Alexa-InlB and HGF in Grb2-depleted cells compared to Grb2-depleted cells expressing EYFP only. Conversely, expression of the chimeric protein deficient in cMet binding (Cbl-SH2/R86A) was not as effective at rescuing cMet internalization in Grb2-depleted cells. Similarly, overexpresion of wt Cbl or Grb2/R86A (a Grb2 mutant deficient in cMet binding) did not reverse the inhibitory effect of siRNA-mediated Grb2 depletion on cMet internalization. Together, these data suggest that the major role of Grb2 in cMet endocytosis is to recruit Cbl to the receptor.
The signaling adaptor Gab1 is not required for cMet internalization-In addition to binding Cbl, Grb2 has been shown to bind Gab1, an adaptor protein that mediates almost all of the signaling cascades downstream from activated cMet including phosphatidylinositol 3-kinase (PI3K), JNK and ERK signaling (reviewed in 63). Gab1 is recruited to cMet by two mechanisms. The primary mechanism involves the indirect recruitment of Gab1 to cMet via Grb2 (35, 38 (64) . To examine the importance of Gab1 in cMet internalization, a Gab1 specific siRNA was used to deplete T47D/cMet cells of endogenous Gab1. Western analysis confirmed the specificity of the siRNAmediated Gab1 knockdown in cells transfected with Gab1 but not a scrambled control (Con) siRNA (Fig. 6A) . Comparable levels of Cbl, actin, Grb2, transferrin receptor (TfR) and cMet were detected in Gab1-depleted cells, as well as mock transfected cells and cells transfected with a control siRNA. Western analysis confirmed that siRNA-depletion of Gab1 did not inhibit ligand induced cMet phosphorylation and ubiquitination, or Cbl phosphorylation (Fig. 6B) . To examine the effect of Gab1 depletion on cMet internalization, siRNA-treated cells were incubated with InlB (100 ng/ml for 10 min at 37°C) to activate cMet signaling, and the relative amounts of residual cell surface cMet were measured using flow cytometry (Fig. 6C) . Comparable levels of cell surface cMet were detected in control and Gab1-depleted cells indicating that siRNA-mediated knockdown of Gab1 did not inhibit cMet internalization in response to InlB. Confocal microscopy studies confirmed that cMet internalization in response to InlB or HGF was not decreased in Gab1 depleted T47D/cMet cells or cells transfected with a control siRNA (data not shown). Thus loss of Gab1 does not block clathrin-mediated cMet internalization.
The direct binding of Grb2 to the multisubstrate docking site of cMet promotes receptor endocytosis -A similar role for Grb2 and Cbl in EGFR internalization has been reported (17, 18, 21, 22) , suggesting a general role for these proteins in RTK endocytosis. However, it is unclear whether Grb2 functions by directly interacting with cMet at phosphotyrosine 1356. Alternatively, the ability of the adaptor Shc to recruit Grb2 indirectly to cMet (56) , may underlie the requirement for Grb2 in cMet endocytosis. To distinguish between these possibilities, we generated a polyclonal cell line using cMet -/-null cells expressing moderate levels of the cMet mutant N1358H (NH-cMet). N1358H is a wellcharacterized mutation that specifically interferes with the direct binding of Grb2 to cMet with no measurable effect on the recruitment of other signaling or adaptor molecules including Shc (29, 65) . Surface biotinylation studies confirmed that like wt-cMet, the mutant receptor NH-cMet was expressed at the cell surface (Fig. 7A) . GST pull down assays confirmed that recombinant Grb2 bound to wt-cMet in response to InlB. Conversely, Grb2 binding to NH-cMet was inhibited under these conditions (Fig. 7B) . cMet ubiquitination and Cbl phosphorylation in response to InlB was detectable in null cells expressing wt-cMet but reduced in cells expressing the mutant NH-cMet (Fig. 7C) . These data support the conclusion that the direct binding of Grb2 to the docking site of cMet is inhibited by the mutation N1358H. We next compared the internalization properties of NH-cMet with the wild type receptor. Using Alexa-InlB to stimulate cMet internalization (10 min, 37°C), we confirmed that cMet internalization was reduced in cMet null cells stably expressing NH-cMet but not in cMet null cells stably expressing wt-cMet by confocal microscopy (Fig. 7D ). To confirm our confocal studies, we used flow cytometry analysis to compare the internalization properties of wt and NH-cMet. Cells were incubated in media containing 100 ng/ml InlB for increasing periods of time at 37°C and processed for flow cytometry. Under these conditions, the cell surface levels of NH-cMet remained unaltered over the course of the experiment. Conversely, cell surface levels of wt-cMet decreased to 35.7 ± 7.6% following treatment with 100 ng/ml InlB for 20 min (Fig.  7E) .
In contrast to our results above, Shc has been reported to regulate EGFR internalization (66), consistent with a role for the indirect recruitment of Grb2 for receptor internalization. To confirm that Shc is dispensable for cMet internalization, we used a siRNA approach in cMet -/-cells stably expressing wt-cMet. Western analysis detected reduced levels of all three endogenous Shc proteins measuring 46, 52 and 66 kD in cells transfected with Shc-siRNA, but not in mock transfected cells or cells transfected with a scrambled control siRNA (Fig. 8A) . A nonspecific immunoreactive band was routinely detected using Shc specific antibodies, consistent with previous reports using other cell lines (67) . Comparable levels of actin and Grb2 were detected in Shcdepleted cells, as well as mock transfected cells and cells transfected with a control siRNA. We quantified the effects of siRNA-mediated Shc depletion on cMet internalization using flow cytometry analysis. Comparable levels of cell by guest on September 1, 2017 http://www.jbc.org/ Downloaded from surface cMet were detected in cells transfected with control or Shc-siRNAs following treatment with 100 ng/ml InlB at all internalization times (Fig. 8B) , indicating that cMet internalization is not dependent on the indirect recruitment of Grb2 through the adaptor Shc.
DISCUSSION
It was unclear whether the regulatory mechanisms for clathrin-mediated endocytosis vary for different RTK subfamilies. cMet and its oncogene TPR-Met are unique amongst RTKs in that two key tyrosine residues in their C-terminal multisubstrate docking sites mediate all of the biological and transforming activities of these receptors. In this study we examined the role of these tyrosines and their ability to bind specific signaling proteins for the internalization of the proto-oncogene cMet. Using variant forms of cMet with altered catalytic and binding properties, we demonstrate that clathrin-dependent cMet internalization is dependent on both the intrinsic kinase activity of the receptor and the recruitment of signaling molecules to phosphotyrosines 1349 and 1356 in the unique multisubstrate docking site of cMet. Depletion of Gab1 using siRNA did not inhibit cMet internalization. However, the levels of Gab1 were reduced but not abrogated in these studies, suggesting that low levels of Gab1 could be sufficient to allow cMet internalization. In a separate study, we detected comparable levels of internalized cMet in mouse embryonic fibroblasts isolated from Gab1 null mice and a mouse embryonic fibroblast cell line isolated from their wild type litter mates stably expressing wt-cMet (unpublished data). Thus we conclude that the recruitment of the signaling adaptor Gab1 was dispensable for cMet internalization. Our studies are the first to show a strict requirement for the ubiquitin ligase activity of Cbl for the internalization of complexes formed between cMet and two soluble receptor ligands, HGF and InlB. Consistent with a role for Cbl ubiquitin ligase activity, over expression of an ubiquitin mutant that could not be conjugated to substrates yet retained the ability to bind to an UIM blocked ligand-induced cMet internalization. Together, our results broaden the roles of Grb2 and Cbl ubiquitin ligase activity to cMet internalization, a receptor tyrosine kinase with unique structural and signaling characteristics.
A similar role for Grb2 has been reported for the EGFR. EGFR internalization through clathrincoated pits was specifically blocked in Grb2-depleted cells (17) . The block in EGFR internalization imposed by Grb2 depletion was rescued by transient expression of a Grb2-Cbl chimera (22). Over expression of Grb2-SH3 mutants deficient in binding downstream signaling molecules inhibited the recruitment of EGFR to clathrin-coated pits (18) and prevented the translocation of Grb2 with activated EGFR into endocytic structures, presumably endocytic transport vesicles (48) . In a separate study, over expression of Grb2 with inactivating point mutations in the SH3 domains inhibited EGFinduced coated pit formation, with negligible effects on the downstream activation of mitogenactivated protein kinase (MAPK) or PI3K (19) . Our studies showing that Grb2-mediated internalization of cMet was dependent on the ubiquitin ligase activity of Cbl are consistent with several models for EGFR internalization, in which the Grb2-Cbl complex likely functions to couple distinct stages of RTK endocytosis (20, 22, 68) .
The multi adaptor Gab1 plays a critical role in cMet signaling by providing a scaffold for the simultaneous activation of several downstream signaling cascades including the activation of PI3K, JNK and ERK signaling (reviewed in 63). Our data showing that the recruitment of Gab1 to cMet is dispensable for receptor internalization are consistent with our previous report that PI3K signaling was not required for cMet endocytosis (3). cMet internalization was unaffected by over expression of a dominant negative mutant for the p85 subunit of PI3K. Similarly, no differences in the internalization properties of cMet were observed in T47D/cMet cells treated with the PI3K inhibitors LY294002 or Wortmannin (3). Thus while Gab1 likely regulates the intensity and duration of cMet signaling, this does not appear to occur at the level of receptor internalization.
The recruitment of Grb2 directly or indirectly via the adaptor Shc to phosphotyrosine 1356 of cMet, is essential for cell transformation and experimental metastases in response to oncogenic Met (69) . The ability of Shc to form a stable complex with Grb2 in response to HGF (56) and EGF (70, 71) suggested that Grb2 recruited indirectly via Shc could regulate RTK endocytosis. Our data showing that cMet internalization was impaired by the N1358H mutation, suggested that the direct recruitment of Grb2 to cMet rather than Grb2 recruited indirectly through Shc mediates cMet internalization, since Shc binding is unaffected by the N1358H mutation (29, 65) . Consistent with this idea, siRNAmediated Shc depletion did not interfere with cMet internalization through clathrin-coated pits. Thus in light of our observations, we propose that Grb2 bound directly to cMet is indispensable for receptor endocytosis. In contrast to cMet, Shc has been reported to play a role in EGF-induced EGFR internalization (66, 72) . EGF has been shown to promote the formation of a complex between wild type Shc and the adapter complex AP2 that is recruited to phosphotyrosine 1148 of the EGFR. Consistent with a role for Shc in EGFR endocytosis, the internalization rate constant of an EGFR truncation mutant lacking the region encompassing phosphotyrosine 1148 was significantly slower than that observed for the wild type receptor (73) . Thus the mode of Grb2 recruitment appears to diverge for cMet versus EGFR internalization, suggesting that distinct subsets of Grb2-mediated interactions are involved in the clathrin dependent internalization of different RTKs.
The precise mechanism by which Cbl regulates cMet internalization, and RTK endocytosis in general, remains controversial. Cbl can be viewed as a bimodal molecule that functions as an adaptor protein that physically links Cbl/cMet complexes to the endocytic machinery (4) and as an E3 ubiquitin ligase to ubiquitinate cMet (13, 14) and its associated endocytic components. While Grb2 and Cbl ubiquitin ligase activity were recently reported to be important for L. monocytogenes infection (5), these studies focused on the internalization of Listeria expressing surface anchored InlB and not soluble InlB. Moreover, these studies did not examine cMet internalization directly but instead monitored bacterial engulfment. A role for Cbl as an adaptor that links HGF-activated cMet to the endophillin-CIN85 complex (4) has been clearly demonstrated. In these studies, inhibition of complex formation using dominant interfering forms of endophilin, CIN85 or Cbl was sufficient to inhibit cMet internalization and enhance cMet signaling. However, these studies did not address the requirement for Cbl ubiquitin ligase activity in this event or the mode of Cbl recruitment to cMet. Our studies showing that expression of a Cbl mutant deficient in ubiquitin ligase activity blocks cMet internalization and that a Grb2-Cbl chimera rescues receptor endocytosis in cells depleted of endogenous Grb2, are the first to show a definitive role for Cbl ubiquitin ligase activity in this process. Moreover, our studies indicate that Grb2 functions as a critical intermediary for Cbl ubiquitin ligase activity in the internalization of soluble InlB/cMet and HGF/cMet complexes. Cbl has been shown to mediate ubiquitination of cMet in response to HGF (43) , in a process that involves the phosphotyrosine 1003 residue in the juxtamembrane region of cMet (13, 14, 42, 74) . The observation that internalization of an ubiquitination-deficient Y1003F-cMet mutant is unaffected, implies that receptor ubiquitination may not be a critical determinant for receptor internalization.
Rather, Cbl-mediated ubiquitination of cMet via phosphotyrosine 1003 is important for degradation of the internalized receptor (13) . Since the Y1003F-cMet was weakly ubiquitinated, we cannot rule out the possibility that different levels of, or sites of cMet ubiquitination contribute to distinct steps for cMet endocytic trafficking. Alternatively, clathrindependent internalization and receptor degradation may be regulated by the indirect recruitment of Cbl via Grb2 to phosphotyrosine 1356, versus Cbl recruited directly to phosphotyrosine 1003 respectively.
In conclusion our data demonstrate a strict requirement for a specific subset of Grb2-mediated interactions for cMet internalization from the cell surface. The direct binding of Grb2 to cMet is essential for receptor internalization. Moreover, endocytosis of soluble InlB/cMet and HGF/cMet complexes is dependent on the E3 ubiquitin ligase activity of Cbl, and does not involve the Grb2 binding partner Gab1. Thus Grb2 functions as an important intermediary for linking ligand-activated cMet with the ubiquitin ligase activity of Cbl for receptor internalization via clathrin-coated pits. A. cMet signaling in stable cMet null (-/-) cells expressing wt, kinase dead (KinD) or a mutant deficient in Grb2 and Gab1 binding (YF) was examined after incubation with (+) or without (-) 100 ng/ml InlB for 15 min at 37°C by immunoprecipitation (IP) and western analysis (IB) for expression of total protein (cMet, Cbl), cMet ubiquitination (Ub) and phosphorylation (P-Met), and Cbl phosphorylation using the antiphosphotyrosine antibody PY20. The positions of molecular weight markers are indicated (kD). B. Biotinylation assays verified that wt and mutant cMet were expressed at comparable levels on the cell surface. C. Grb2 binding was detected in null (-/-) cells stably expressing wt but not mutant cMet in response to treatment with 100 ng/ml InlB. D. Gab1 was phosphorylated in response to treatment with (+) 100 ng/ml InlB in cells expressing wt, but not mutant cMet. E. cMet null (-/-) cells expressing wt or the indicated cMet mutants were left untreated (0 min) or treated with 100 ng/ml InlB for 5, 10 or 20 min at 37°C. The cells were chilled to 4°C and cMet on the cell surface specifically labeled with anti-cMet antibody and quantified by flow cytometry. Results represented the mean fluorescent intensities normalized to untreated cells under each experimental condition from triplicate experiments. Bars represent the means for data across all experiments with S.E. A. Western analysis of lysates from mock transfected (UN) and T47D/cMet cells transfected with control (Con) or Gab1 siRNAs confirmed specific knock down of Gab1. B. T47D/cMet cells were transfected with the indicated siRNAs, following treatment with (+) or without (-) 100 ng/ml InlB for 10 min at 37°C. Equal amounts of lysates were examined by immunoprecipitation (IP) and western analysis (IB) for total protein (cMet, Gab1 and Cbl), cMet phosphorylation (P-Met) and ubiquitination (Ub), and Cbl phosphorylation (PY20) as indicated. C. T47D/cMet cells transfected with control or Gab1 specific siRNAs were treated with 100 ng/ml InlB for the indicated times at 37°C and surface cMet levels quantified by flow cytometry analysis. Western analysis of lysates from mock transfected (UN) and cMet null cells expressing wt-cMet transfected with control (Con) or Shc siRNAs for Shc, actin and Grb2 confirmed specific knock down of the three family members of Shc. Asterisk (*) indicates a nonspecific immunoreactive band. B. cMet -/-cells stably expressing wt-cMet were transfected with control or Shc specific siRNAs then treated with 100 ng/ml InlB for the indicated times at 37°C and surface cMet levels quantified by flow cytometry analysis. Results are graphed as a percentage of total surface cMet ± S.E. prior to internalization.
